Trenbolone acetate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 04:49, 30 November 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Trenbolone acetate
Clinical data
Other namesRU-1697
Routes of
administration
Intramuscular injection
Identifiers
  • [(8S,13S,14S,17S)-13-Methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.030.380 Edit this at Wikidata
Chemical and physical data
FormulaC20H24O3
Molar mass312.409 g/mol g·mol−1
3D model (JSmol)
  • CC(=O)O[C@H]1CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)C
  • InChI=1S/C20H24O3/c1-12(21)23-19-8-7-18-17-5-3-13-11-14(22)4-6-15(13)16(17)9-10-20(18,19)2/h9-11,17-19H,3-8H2,1-2H3/t17-,18+,19+,20+/m1/s1
  • Key:CMRJPMODSSEAPL-FYQPLNBISA-N

Trenbolone acetate (USAN, BANM) (brand names Revalor (in combination with estradiol), Finaplix, Finajet; former developmental code name RU-1697), also known as 19-nor-δ9,11-testosterone 17β-acetate or as 19-norandrost-4,9,11-trien-17β-ol-3-one 17β-acetate, is a synthetic, injected anabolic-androgenic steroid (AAS) and derivative of 19-nortestosterone (nandrolone) that is used in veterinary medicine.[1][2][3] It is the C17β acetate ester and a long-acting prodrug of trenbolone (19-nor-δ9,11-testosterone).[1][2][3]

See also

References

  1. ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 472. ISBN 978-1-4757-2085-3.
  2. ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. p. 1591. ISBN 978-3-88763-075-1.
  3. ^ a b I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 279–. ISBN 978-94-011-4439-1.